Drawing for BASEPOINT

USPTO serial 88870009

BASEPOINT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
VENGROFF, MARILYN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BASEPOINT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michele H. Bowman

100 ABBOTT PARK ROADABBOTT PARK, IL 60064UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic test kits comprised of medical diagnostic reagents for testing bodily fluids for use in detecting, diagnosing, screening, and confirming infectious disease, respiratory infection, pregnancy, ovulation, cardiovascular disease, hospital acquired infection, blood borne pathogens, enterics, vector borne pathogens, sexually transmitted infection, tropical disease infection, cancer, drugs, and alcohol; medical diagnostic test strips for use in detecting, diagnosing, screening, and confirming infectious disease, respiratory infection, pregnancy, ovulation, cardiovascular disease, hospital acquired infection, blood borne pathogens, enterics, vector borne pathogens, sexually transmitted infection, tropical disease infection, cancer, drugs, and alcohol; medical diagnostic reagents; diagnostic preparations for medical purposes; testing preparations for medical use, namely, for testing for infectious disease, respiratory infection, pregnancy, ovulation, cardiovascular disease, hospital acquired infection, blood borne pathogens, enterics, vector borne pathogens, sexually transmitted infection, tropical disease infection, cancer, drugs, and alcohol; diagnostic tests in the nature of reagents and assays for testing of body fluids for medical use; medical diagnostic assays; solutions used in medical diagnostic test kits, namely, solutions for medical and clinical use in testing for infectious disease, respiratory infection, pregnancy, ovulation, cardiovascular disease, hospital acquired infection, blood borne pathogens, enterics, vector borne pathogens, sexually transmitted infection, tropical disease infection, cancer, drugs, and alcohol; cartridges containing reagents for medical diagnostic test use; cartridges containing medical diagnostic reagents; test cartridges containing chemical reagents for in vitro diagnostic medical testing; medical reagents contained in a cartridge for medical diagnostic use; in vitro diagnostic reagents contained in pre-filled cartridges for medical use; medical diagnostics tests for the detection, diagnosis, screening, and confirmation of infectious diseases; medical kits comprising reagents and assays for testing for the presence of antigens in blood, human serum, plasma, urine, other biological fluids, and tissue; chromatographic immunoassay tests for medical use; testing kits comprised of medical diagnostic reagents and assays for detecting alcohol and drugs; drug and alcohol testing panels, namely, medical diagnostic reagents and assays for testing bodily fluids for the presence of drugs and alcoholACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 22, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 21, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 20, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 25, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 25, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 5, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 20, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 7, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 7, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2021ALIEASSIGNED TO LIE—
Jan 6, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2020DOCKASSIGNED TO EXAMINER—
Apr 21, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance